Cargando…
The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry
Liquid-chromatography mass spectrometry is commonly used to identify and quantify metabolites from biological samples to gain insight into human physiology and pathology. Metabolites and their abundance in biological samples are labile and sensitive to variations in collection conditions, handling a...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571950/ https://www.ncbi.nlm.nih.gov/pubmed/31126114 http://dx.doi.org/10.3390/biom9050200 |
_version_ | 1783427528250097664 |
---|---|
author | Khadka, Manoj Todor, Andrei Maner-Smith, Kristal M. Colucci, Jennifer K. Tran, ViLinh Gaul, David A. Anderson, Evan J. Natrajan, Muktha S. Rouphael, Nadine Mulligan, Mark J. McDonald, Circe E. Suthar, Mehul Li, Shuzhao Ortlund, Eric A. |
author_facet | Khadka, Manoj Todor, Andrei Maner-Smith, Kristal M. Colucci, Jennifer K. Tran, ViLinh Gaul, David A. Anderson, Evan J. Natrajan, Muktha S. Rouphael, Nadine Mulligan, Mark J. McDonald, Circe E. Suthar, Mehul Li, Shuzhao Ortlund, Eric A. |
author_sort | Khadka, Manoj |
collection | PubMed |
description | Liquid-chromatography mass spectrometry is commonly used to identify and quantify metabolites from biological samples to gain insight into human physiology and pathology. Metabolites and their abundance in biological samples are labile and sensitive to variations in collection conditions, handling and processing. Variations in sample handling could influence metabolite levels in ways not related to biology, ultimately leading to the misinterpretation of results. For example, anticoagulants and preservatives modulate enzyme activity and metabolite oxidization. Temperature may alter both enzymatic and non-enzymatic chemistry. The potential for variation induced by collection conditions is particularly important when samples are collected in remote locations without immediate access to specimen processing. Data are needed regarding the variation introduced by clinical sample collection processes to avoid introducing artifact biases. In this study, we used metabolomics and lipidomics approaches paired with univariate and multivariate statistical analyses to assess the effects of anticoagulant, temperature, and time on healthy human plasma samples collected to provide guidelines on sample collection, handling, and processing for vaccinology. Principal component analyses demonstrated clustering by sample collection procedure and that anticoagulant type had the greatest effect on sample metabolite variation. Lipids such as glycerophospholipids, acylcarnitines, sphingolipids, diacylglycerols, triacylglycerols, and cholesteryl esters are significantly affected by anticoagulant type as are amino acids such as aspartate, histidine, and glutamine. Most plasma metabolites and lipids were unaffected by storage time and temperature. Based on this study, we recommend samples be collected using a single anticoagulant (preferably EDTA) with sample processing at <24 h at 4 °C. |
format | Online Article Text |
id | pubmed-6571950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65719502019-06-18 The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry Khadka, Manoj Todor, Andrei Maner-Smith, Kristal M. Colucci, Jennifer K. Tran, ViLinh Gaul, David A. Anderson, Evan J. Natrajan, Muktha S. Rouphael, Nadine Mulligan, Mark J. McDonald, Circe E. Suthar, Mehul Li, Shuzhao Ortlund, Eric A. Biomolecules Article Liquid-chromatography mass spectrometry is commonly used to identify and quantify metabolites from biological samples to gain insight into human physiology and pathology. Metabolites and their abundance in biological samples are labile and sensitive to variations in collection conditions, handling and processing. Variations in sample handling could influence metabolite levels in ways not related to biology, ultimately leading to the misinterpretation of results. For example, anticoagulants and preservatives modulate enzyme activity and metabolite oxidization. Temperature may alter both enzymatic and non-enzymatic chemistry. The potential for variation induced by collection conditions is particularly important when samples are collected in remote locations without immediate access to specimen processing. Data are needed regarding the variation introduced by clinical sample collection processes to avoid introducing artifact biases. In this study, we used metabolomics and lipidomics approaches paired with univariate and multivariate statistical analyses to assess the effects of anticoagulant, temperature, and time on healthy human plasma samples collected to provide guidelines on sample collection, handling, and processing for vaccinology. Principal component analyses demonstrated clustering by sample collection procedure and that anticoagulant type had the greatest effect on sample metabolite variation. Lipids such as glycerophospholipids, acylcarnitines, sphingolipids, diacylglycerols, triacylglycerols, and cholesteryl esters are significantly affected by anticoagulant type as are amino acids such as aspartate, histidine, and glutamine. Most plasma metabolites and lipids were unaffected by storage time and temperature. Based on this study, we recommend samples be collected using a single anticoagulant (preferably EDTA) with sample processing at <24 h at 4 °C. MDPI 2019-05-23 /pmc/articles/PMC6571950/ /pubmed/31126114 http://dx.doi.org/10.3390/biom9050200 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khadka, Manoj Todor, Andrei Maner-Smith, Kristal M. Colucci, Jennifer K. Tran, ViLinh Gaul, David A. Anderson, Evan J. Natrajan, Muktha S. Rouphael, Nadine Mulligan, Mark J. McDonald, Circe E. Suthar, Mehul Li, Shuzhao Ortlund, Eric A. The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title | The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title_full | The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title_fullStr | The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title_full_unstemmed | The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title_short | The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry |
title_sort | effect of anticoagulants, temperature, and time on the human plasma metabolome and lipidome from healthy donors as determined by liquid chromatography-mass spectrometry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571950/ https://www.ncbi.nlm.nih.gov/pubmed/31126114 http://dx.doi.org/10.3390/biom9050200 |
work_keys_str_mv | AT khadkamanoj theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT todorandrei theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT manersmithkristalm theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT coluccijenniferk theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT tranvilinh theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT gauldavida theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT andersonevanj theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT natrajanmukthas theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT rouphaelnadine theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT mulliganmarkj theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT mcdonaldcircee theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT sutharmehul theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT lishuzhao theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT ortlunderica theeffectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT khadkamanoj effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT todorandrei effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT manersmithkristalm effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT coluccijenniferk effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT tranvilinh effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT gauldavida effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT andersonevanj effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT natrajanmukthas effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT rouphaelnadine effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT mulliganmarkj effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT mcdonaldcircee effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT sutharmehul effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT lishuzhao effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry AT ortlunderica effectofanticoagulantstemperatureandtimeonthehumanplasmametabolomeandlipidomefromhealthydonorsasdeterminedbyliquidchromatographymassspectrometry |